Vous êtes ici : Infection et inflammation Chronique (2IC)FRLaboratoire U1173

Publications de l'équipe EPIM

2018

 

1.       Nguyen PC, Madani A, Santucci P, Martin BP, Paudel RR, Delattre SHerrmann JL, Spilling CD, Kremer L, Canaan S, Cavalier JF. Cyclophostin and cyclipostins analogs, new promising molecules to treat mycobacterial-related diseases. Int J Antimicrob Agents. 2018; 51: 651-4

2.       Compain F, Soroka D, Heym B, Gaillard JLHerrmann JL, Dorchène D, Arthur M, Dubée V. In vitro activity of tedizolid against the Mycobacterium abscessus complex. Diagn Microbiol Infect Dis. 2018; 90: 186-9

3.       Cagno V, Andreozzi P, D'Alicarnasso M, Jacob Silva P, Mueller M, Galloux M, Le Goffic R, Jones ST, Vallino M, Hodek J, Weber J, Sen S, Janeček ER, Bekdemir A, Sanavio B, Martinelli C, Donalisio M, Rameix Welti MA, Eleouet JF, Han Y, Kaiser L, Vukovic L, Tapparel C, Král P, Krol S, Lembo D, Stellacci F. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat Mater. 2018; 17: 195-203.

4.       Dinh A, Duran C, Davido B, Lagrange A, Sivadon-Tardy V, Bouchand F, Beauchet A, Gaillard JL, Beaune S, Salomon J, Grenet J. Cost effectiveness of pneumococcal urinary antigen in Emergency Department: a pragmatic real-life study. Intern Emerg Med. 2018; 13: 69-73.

5.       Laencina L, Dubois V, Le Moigne V, Viljoen A, Majlessi L, Pritchard J, Bernut A, Piel L, Roux AL, Gaillard JL, Lombard B, Loew D, Rubin EJ, Brosch R, Kremer L, Herrmann JL, Girard-Misguich F. Identification of genes required for Mycobacterium abscessus growth in vivo with a prominent role of the ESX-4 locus. Proc Natl Acad Sci U S A. 2018; 115: E1002-E1011.

6.       Dinh A, Davido B, Bouchand F, Duran C, Ropers J, Crémieux AC. Honey, I shrunk the antibiotic therapy. Clin Infect Dis. 2018 Jan 23. doi: 10.1093/cid/ciy047.

7.       Reissier S, Saleh-Mghir A, Guerin F, Massias L, Ghout I, Sinel C, Cattoir V, Cremieux AC. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis. J Antimicrob Chemother. 2018; 73: 981-86.

8.       Chouirfa H, Evans MDM, Bean P, Saleh-Mghir A, Crémieux AC, Castner DG, Falentin-Daudré C, Migonney V. Grafting of Bioactive Polymers with Various Architectures: A Versatile Tool for Preparing Antibacterial Infection and Biocompatible Surfaces. ACS Appl Mater Interfaces. 2018; 10: 1480-91.

9.       Richard CA, Rincheval V, Lassoued S, Fix J, Cardone C, Esneau C, Nekhai S, Galloux M, Rameix-Welti MA, Sizun C, Eléouët JF. RSV hijacks cellular protein phosphatase 1 to regulate M2-1 phosphorylation and viral transcription. PLoS Pathog. 2018; 14: e1006920.

2017

 

1.       Parra J, Marcoux J, Poncin I, Canaan S, Herrmann JL, Nigou J, Burlet-Schiltz O, Rivière M. Scrutiny of Mycobacterium tuberculosis 19 kDa antigen proteoforms provides new insights in the lipoglycoprotein biogenesis paradigm. Sci Rep. 2017; 7: 43682.

2.       Lefebvre AL, Le Moigne V, Bernut A, Veckerlé C, Compain F, Herrmann JL, Kremer L, Arthur M, Mainardi JL. Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus. Antimicrob Agents Chemother. 2017; 61: pii: e02440-16.

3.       Boucher A, Herrmann JL, Morand P, Buzelé R, Crabol Y, Stahl JP, Mailles A. Epidemiology of infectious encephalitis causes in 2016. Med Mal Infect. 2017; 47: 221-35

4.       Viljoen A, Dubois V, Girard-Misguich F, Blaise M, Herrmann JL, Kremer L. The diverse family of MmpL transporters in mycobacteria: From regulation to antimicrobial developments. Mol Microbiol. 2017; 104: 889-904.

5.       Bouchand F, Dinh A, Roux AL, Davido B, Michelon H, Lepainteur M, Legendre B, El Sayed F, Pierre I, Salomon J, Lawrence C, Perronne C, Villart M, Crémieux AC. Implementation of a simple innovative system for postprescription antibiotic review based on computerized tools with shared access. J Hosp Infect. 2017; 95: 312-7.

6.       Bernut A, Herrmann JL, Ordway D, Kremer L. The Diverse Cellular and Animal Models to Decipher the Physiopathological Traits of Mycobacterium abscessus Infection. Front Cell Infect Microbiol. 2017; 7: 100.

7.       Davido B, Fellous L, Lawrence C, Maxime V, Rottman M, Dinh A. Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017; 61. pii: e01008-17.

8.       Dinh A, Davido B, Calin R, Paquereau J, Duran C, Bouchand F, Phé V, Chartier-Kastler E, Rottman M, Salomon J, Plésiat P, Potron A. Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder. Spinal Cord Ser Cases. 2017; 3: 17019.

9.       Stahl JP, Azouvi P, Bruneel F, De Broucker T, Duval X, Fantin B, Girard N, Herrmann JL, Honnorat J, Lecuit M, Mailles A, Martinez-Almoyna L, Morand P, Piroth L, Tattevin P; reviewing group. Guidelines on the management of infectious encephalitis in adults. Med Mal Infect. 2017; 47: 179-94.

10.    Dupont C, Viljoen A, Thomas S, Roquet-Banères F, Herrmann JL, Pethe K, Kremer L. Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish. Antimicrob Agents Chemother. 2017; 61. pii: e01225-17.

11.    Blischak JD, Tailleux L, Myrthil M, Charlois C, Bergot E, Dinh A, Morizot G, Chény O, Platen CV, Herrmann JL, Brosch R, Barreiro LB, Gilad Y. Predicting susceptibility to tuberculosis based on gene expression profiling in dendritic cells. Sci Rep. 2017; 7: 5702.

12.    Mellon G, Delanoe C, Roux AL, Heym B, Dubourg O, Hardy P, Chevallier B, Perronne C, Rouveix E, Salomon J. Non-typhi Salmonella enterica urinary tract infections. Med Mal Infect. 2017; 47: 389-393.

13.    Dinh A, Duran C, Davido B, Calin R, Roux AL, Salomon J. Breast abscess due to Bacillus Calmette-Guérin. Int J Infect Dis. 2017; 59: 137-8.

14.    Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, Casartelli N, Rameix-Welti MA, Hervé PL, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, Descamps D, Fix J, Eléouët JF, Riffault S, Schwartz O, Porcheray F, Mascart F, Mouquet H, Zhang X, Tissières P, Lo-Man R. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity. Immunity. 2017; 46: 301-14.

15.    Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O. A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading. Antimicrob Agents Chemother. 2017; 61. pii: e02241-16.

16.    Hervé PL, Deloizy C, Descamps D, Rameix-Welti MA, Fix J, McLellan JS, Eléouët JF, Riffault S. RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine. Nanomedicine. 2017; 13: 411-20.

17.    Benzerara Y, Gallah S, Hommeril B, Genel N, Decré D, Rottman M, Arlet G. Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France. Emerg Infect Dis. 2017 Sep;23(9):1564-7.

18.    Viljoen A, Herrmann JL, Onajole OK, Stec J, Kozikowski AP, Kremer L. Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport. Front Cell Infect Microbiol. 2017; 7: 388.

19.    Fabre-Baudouin A, Roux AL, Marin C, Lachatre M, De Laroche M, Ponsoye M, Hanslik T, Trad S. Diagnostic issues of lymphogranuloma venereum: A case series of 5 patients. Rev Med Interne. 2017; 38: 794-9.

20.    Rincheval V, Lelek M, Gault E, Bouillier C, Sitterlin D, Blouquit-Laye S, Galloux M, Zimmer C, Eleouet JF, Rameix-Welti MA. Functional organization of cytoplasmic inclusion bodies in cells infected by respiratory syncytial virus. Nat Commun. 2017 Sep 15;8(1): 563.

21.    Kernéis S, Plainvert C, Barnier JP, Tazi A, Dmytruk N, Gislain B, Loubinoux J, El Sayed F, Cattoir V, Desplaces N, Vernet V, Morand P, Poyart C. Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014. Eur J Clin Microbiol Infect Dis. 2017; 36: 1679-84.

22.    Vasou A, Paulus C, Narloch J, Gage ZO, Rameix-Welti MA, Eléouët JF, Nevels M, Randall RE, Adamson CS. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice. Antiviral Res. 2017; 150: 79-92.

23.    Leblanc J, Hejblum G, Costagliola D, Durand-Zaleski I, Lert F, de Truchis P, Verbeke G, Rousseau A, Piquet H, Simon F, Pateron D, Simon T, Crémieux AC; DICI-VIH (Dépistage Infirmier CIblé du VIH) Group. Targeted HIV Screening in Eight Emergency Departments: The DICI-VIH Cluster-Randomized Two-Period Crossover Trial. Ann Emerg Med. 2017 ; pii: S0196-0644(17)31660-8.

24.    Dinh A, Demay O, Rottman M, Gaudot F, Bougnoux ME, Bouchand F, Coignard H, Rouzaud C, Davido B, Duran C, Nich C. Case of femoral pseudarthrosis due to Scedosporium apiospermum in an immunocompetent patient with successful conservative treatment and review of literature. Mycoses. 2017 Dec 23. doi: 10.1111/myc.12739.

25.    Repessé X, Artiguenave M, Paktoris-Papine S, Espinasse F, Dinh A, Charron C, El Sayed F, Geri G, Vieillard-Baron A. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an intensive care unit with no single rooms. Ann Intensive Care. 2017; 7: 73.